封面
市場調查報告書
商品編碼
1967564

腸內支架市場:市場規模、佔有率、監管、報銷、介入治療及2036年預測(依細分市場劃分)

Enteral Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

腸內支架市場-市場規模、佔有率、監管、報銷、介入治療及2036年預測(依細分市場劃分)-旨在可視化呈現一般外科器械治療領域的定量和定性市場趨勢。

腸內支架是一種可穿透的擴張管,插入體內通道以緩解疾病引起的血流阻塞。它們主要用於維持胃腸道管腔的通暢。腸內支架是一種安寧療護措施,適用於有胃腸道阻塞風險的患者。

腸內支架是一種安寧療護措施,適用於有胃腸道阻塞風險的患者。 高風險患者通常患有食道癌、胰腺癌、胃癌或大腸癌,腫瘤要么直接侵犯胃腸道,要么造成危險的壓迫。腸內支架能夠維持胃腸道通暢,並顯著改善患者的生活品質。

涵蓋的39個國家的市場模型均採用顏色編碼,並包含完整的資料來源,其中包括基於流行病學的適應症和乾預次數。互動式Excel表格提供價值、銷售、產品使用率、平均售價、市場規模和公司佔有率分析(如有)。此外,分析師的評論和定性見解為定量數據提供了背景資訊。

市場模型的關鍵組成部分包括:

目前可用的腸內支架及不斷變化的競爭格局

  • 對關鍵產業趨勢的深入分析
  • 2015年至2036年腸內支架市場依細分市場劃分的年度總收入及市場預測
  • 依細分市場劃分的介入治療總數、銷售量、平均售價和市場規模的詳細數據

全球、區域和國家層面的市場洞察

  • 除了定性的市場特定資訊外,我們還提供依區域劃分的全球趨勢細分分析。此外,GlobalData分析師也提供針對特定國家市場的獨特見解。
  • 腸內支架市場的SWOT分析。
  • 腸內支架市場的競爭格局與趨勢。

全面、整體的視角,包括對醫療保健系統的概述,有助於加深對市場的理解。此外, "市場准入" 部分透過報銷政策和監管環境的訊息,使用戶能夠更深入地了解市場動態。

  • 各國醫療保健系統概述。
  • 各國報銷政策。
  • 各國醫療科技監管環境。

憑藉可靠的研究方法和資料來源,該模型提供了全面而準確的市場概覽。主要需求和供應方資訊被整合到一個包含關鍵產業專家的綜合模型中。此外,還利用政府程式資料庫、醫院採購資料庫和專有線上資料庫等真實世界資料來源來確定市場趨勢。

涵蓋的公司包括:波士頓科學公司、威爾遜-庫克醫療公司、美瑞醫療系統公司、南京微科醫療股份有限公司、泰雄醫療股份有限公司、邁泰醫療股份有限公司等。

涵蓋國家:美國、英國、德國、法國、義大利、西班牙、巴西、中國、印度、俄羅斯、日本、澳洲、加拿大、墨西哥、韓國、丹麥、愛爾蘭、荷蘭、紐西蘭、南非、瑞典、瑞士、奧地利、比利時、芬蘭、以色列、挪威、波蘭、葡萄牙、台灣、捷克、希臘、匈牙利、土耳其、埃及、沙烏地阿拉伯、阿拉伯聯合大公國、阿根廷和智利。

適用範圍

此市場模型提供其他地方無法獲得的關鍵專業知識。該模型揭示了特定市場內的定性和定量趨勢。以下人員必須閱讀此模型:

  • 需要深入了解腸內支架市場以指導策略規劃和投資決策的首席行銷長 (CMO)。
  • 需要了解供應鏈關鍵組成部分以做出供應商選擇和管理決策的採購主管。
  • 私募股權投資者需要更深入地了解市場,以便識別和評估潛在的投資目標。

購買理由

此模型可協助您:

  • 透過產品線審查識別關鍵公司,並制定和設計許可引進和許可輸出策略。
  • 了解影響和驅動腸內支架市場的趨勢,並制定業務策略。
  • 透過了解關鍵趨勢、創新產品和技術、市場細分以及未來可能影響腸內支架市場的公司,實現收入成長。
  • 了解競爭格局,並分析市場領導者的市場佔有率,以製定有效的銷售和行銷策略。
  • 識別具有潛在強大產品組合的新興公司,並制定有效的應對策略以獲得競爭優勢。
  • 追蹤2015年至2036年全球及各國腸道支架市場的銷售情況。
  • 識別最具整合、投資和策略聯盟機會的市場類別和細分市場,以優化您的銷售和行銷策略。
簡介目錄
Product Code: GDME596MM

Enteral Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.

An Enteral Stent is a perforated expandable tube which is inserted into a passage of the body in order to alleviate the constriction of flow caused by any disease. Enteral stents are primarily used to maintain patency of the lumen of the gastrointestinal tract. Enteral stents are a palliative measure, used in patients who are at risk of suffering from a blocked gastrointestinal passage.

Enteral stents are a palliative measure, used in patients who are at risk of suffering from a blocked gastrointestinal passage. Those who are at risk are usually suffering from esophogeal, pancreatic, gastric, or colorectal cancer and have tumors that either directly invade the gastrointestinal tract, or cause dangerous compression. Enteral stents can allow the gastrointestinal lumen to stay open, which can drastically improve the quality of life for the patient.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with Intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Enteral Stents and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Enteral Stents market revenue by segment and market outlooks from 2015-2036.
  • Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Enteral Stents market.
  • Competitive dynamics insights and trends provided for Enteral Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Wilson-Cook Medical Inc, Merit Medical Systems Inc, Micro-Tech Nanjing Co Ltd, Taewoong Medical Co Ltd, MITech Co Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Enteral Stents marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Enteral Stents market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Enteral Stents market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Enteral Stents market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.